AGP Picks
View all

Middle East News Network
Provided by AGP

Middle East News Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Network.

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

Press releases published on June 1, 2026

PolyPid Completes New Drug Application Submission to FDA for D-PLEX₁₀₀
Jun. 1, 2026

PolyPid Completes New Drug Application Submission to FDA for D-PLEX₁₀₀

Indeterminate GlobeNewswire
Fate Therapeutics Showcases Clinical Data for FT836 at the American Society of Cancer Oncology Annual Meeting
Jun. 1, 2026

Fate Therapeutics Showcases Clinical Data for FT836 at the American Society of Cancer Oncology Annual Meeting

Indeterminate GlobeNewswire
Cosmos Health Enters $69 Billion Global Animal Health Industry with Veterinary C-Scrub Wash 4% Following Successful European Standard Testing Under EN 1656 and EN 1657
Jun. 1, 2026

Cosmos Health Enters $69 Billion Global Animal Health Industry with Veterinary C-Scrub Wash 4% Following Successful European Standard Testing Under EN 1656 and EN 1657

Indeterminate GlobeNewswire
Vaxart Files Definitive Proxy Statement and Mails Letter to Shareholders
Jun. 1, 2026

Vaxart Files Definitive Proxy Statement and Mails Letter to Shareholders

Indeterminate GlobeNewswire
K2 Group releases its 2025 Sustainability Report
Jun. 1, 2026

K2 Group releases its 2025 Sustainability Report

Indeterminate EIN Presswire
Amneal to Participate in Goldman Sachs 47th Annual Global Healthcare Conference 2026
Jun. 1, 2026

Amneal to Participate in Goldman Sachs 47th Annual Global Healthcare Conference 2026

Indeterminate GlobeNewswire
Nasus Pharma to Host Virtual KOL Event on June 10, 2026 to Discuss NS002 for the Treatment of Anaphylaxis
Jun. 1, 2026

Nasus Pharma to Host Virtual KOL Event on June 10, 2026 to Discuss NS002 for the Treatment of Anaphylaxis

Indeterminate GlobeNewswire
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jun. 1, 2026

Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Lyell Immunopharma Announces Participation in Goldman Sachs 47th Annual Global Healthcare Conference 2026
Jun. 1, 2026

Lyell Immunopharma Announces Participation in Goldman Sachs 47th Annual Global Healthcare Conference 2026

Indeterminate GlobeNewswire
Aprea Therapeutics Presents Updated Phase 1 Data on WEE1 Inhibitor APR-1051 at ASCO 2026, Demonstrating Early Monotherapy Activity and Manageable Tolerability in Advanced Solid Tumors
Jun. 1, 2026

Aprea Therapeutics Presents Updated Phase 1 Data on WEE1 Inhibitor APR-1051 at ASCO 2026, Demonstrating Early Monotherapy Activity and Manageable Tolerability in Advanced Solid Tumors

Indeterminate GlobeNewswire
ALX Oncology to Present at the 2026 Jefferies Global Healthcare Conference in New York
Jun. 1, 2026

ALX Oncology to Present at the 2026 Jefferies Global Healthcare Conference in New York

Indeterminate GlobeNewswire
Allocetra Shows Durable 6-Month Efficacy in Knee Osteoarthritis Phase IIa Trial; Oral Presentation at EULAR 2026
Jun. 1, 2026

Allocetra Shows Durable 6-Month Efficacy in Knee Osteoarthritis Phase IIa Trial; Oral Presentation at EULAR 2026

Indeterminate GlobeNewswire
Nayax Launches AI-Powered Product Discovery for Retailers
Jun. 1, 2026

Nayax Launches AI-Powered Product Discovery for Retailers

Indeterminate GlobeNewswire
DEEP SEA MINERALS CORP. ACHIEVES SUBSTANTIAL COMPLIANCE DETERMINATION FROM NOAA UNDER DSHMRA FOR SEABED MINERAL CONCESSIONS
Jun. 1, 2026

DEEP SEA MINERALS CORP. ACHIEVES SUBSTANTIAL COMPLIANCE DETERMINATION FROM NOAA UNDER DSHMRA FOR SEABED MINERAL CONCESSIONS

Indeterminate GlobeNewswire
Belo Sun Announces Corporate Update
Jun. 1, 2026

Belo Sun Announces Corporate Update

Indeterminate GlobeNewswire
Invivyd Announces Completion of Enrollment in Upsized DECLARATION Clinical Trial, a Phase 3 Pivotal Study of VYD2311, an Investigational Antibody to Prevent COVID
Jun. 1, 2026

Invivyd Announces Completion of Enrollment in Upsized DECLARATION Clinical Trial, a Phase 3 Pivotal Study of VYD2311, an Investigational Antibody to Prevent COVID

Indeterminate GlobeNewswire
Verano Announces 1-for-5 Reverse Stock Split to Prepare the Company for Prospective U.S. Stock Exchange Listing
Jun. 1, 2026

Verano Announces 1-for-5 Reverse Stock Split to Prepare the Company for Prospective U.S. Stock Exchange Listing

Indeterminate GlobeNewswire
NexGold Advancing Key Development Activities on Schedule at the Goldboro Gold Project in Nova Scotia
Jun. 1, 2026

NexGold Advancing Key Development Activities on Schedule at the Goldboro Gold Project in Nova Scotia

Indeterminate GlobeNewswire
Actuate Therapeutics Announces ASCO Poster Presentations Demonstrating Compelling Clinical and Biomarker Data for Elraglusib in First-Line Metastatic Pancreatic Cancer
Jun. 1, 2026

Actuate Therapeutics Announces ASCO Poster Presentations Demonstrating Compelling Clinical and Biomarker Data for Elraglusib in First-Line Metastatic Pancreatic Cancer

Indeterminate GlobeNewswire
Kamada Announces FDA Approval of its New In-House Rabies Virus Neutralization Testing Laboratory
Jun. 1, 2026

Kamada Announces FDA Approval of its New In-House Rabies Virus Neutralization Testing Laboratory

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Middle East News Network

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.